GEN - Genetic Engineering and Biotechnology News

No Pain, No Gain: Insilico ‘Gym’ Gets AI Models Into Shape

Insilico Medicine has launched Science MMAI Gym, a domain-specific training infrastructure designed to transform LLMs into their best shape for drug discovery and development.
Le Lézard

Quince Therapeutics Presents Safety Data from Long-Term eDSP Treatment in Children with Ataxia-Telangiectasia at British Paediatric Neurology Association Annual Meeting

Quince Therapeutics, Inc. , a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced the poster presentation ...
Pharmabiz

Bayer to present new phase III data and advancements of radiology portfolio at ECR 2026

Bayer to present new phase III data and advancements of radiology portfolio at ECR 2026: Berlin Wednesday, January 28, 2026, 13:00 Hrs [IST] Bayer will present advancements of its ...

Eurofins Delivers FY 2025 Objectives with a 24% EPS Growth, Accelerating Organic Revenue Growth, Margin Expansion, and Higher Free Cash Flow and Confirms Its 2027 Objectives

Eurofins (Paris:ERF) pre-publishes below its preliminary unaudited consolidated financial results for the year ending 31 December 2025, as described in the first paragraphA of the Business Review ...
GEN - Genetic Engineering and Biotechnology News

Rethinking Vaccine Production Platforms for Future Pandemics

Yeast-based protein expression systems will likely play an important role in vaccine production during future pandemics.

ExpreS2ion Biotech Holding AB: As Nipah Virus Outbreaks in India Re-emerge, ExpreS2ion Selects Northway Biotech as Manufacturing Partner for Vaccine Program

Hørsholm, Denmark, 28 January 2026 - ExpreS2ion Biotech Holding AB's affiliate ExpreS2ion Biotechnologies ApS ("ExpreS2ion"), a clinical-stage biotechnology company with a focused pipeline of vaccine ...